Clinical trial

The Procalcitonin and Survival Study

NCT00271752 · Danish Procalcitonin Study Group, Other · Completed

Key facts

NCT number NCT00271752
Title The Procalcitonin and Survival Study
Official title The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Acronym PASS
Lead sponsor Danish Procalcitonin Study Group, Other
Collaborators Copenhagen HIV Programme Danish Research Agency Hvidovre University Hospital
Status Completed
Study type Interventional
Conditions Localized Infection, Sepsis, Multiple Organ Failure
Intervention type Procedure
Interventions Earlier therapeutic changes regarding infection
Enrollment 1,200
Start date Jan 1, 2006
Primary completion Sep 1, 2009
Completion Sep 1, 2009
First posted Jan 4, 2006
Last update posted Mar 4, 2010
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies